98-23265. Advisory Committee Meeting; Amendment of Notice  

  • [Federal Register Volume 63, Number 167 (Friday, August 28, 1998)]
    [Notices]
    [Page 46054]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-23265]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Advisory Committee Meeting; Amendment of Notice
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing an 
    amendment to the notice of a joint meeting of the Hematology and 
    Pathology Devices Panel and the Immunology Devices Panel of the Medical 
    Devices Advisory Committee that is scheduled for September 4, 1998. 
    This meeting was announced in the Federal Register of August 13, 1998 
    (63 FR 43401). The amendment is being made to reflect changes in the 
    Date and Time and Procedure portions of the meeting. There are no other 
    changes.
    
    FOR FURTHER INFORMATION CONTACT: Veronica J. Calvin, Center for Devices 
    and Radiological Health (HFZ-440), Food and Drug Administration, 2098 
    Gaither Rd., Rockville, MD 20850, 301-594-1243.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of August 13, 1998 
    (63 FR 43401), FDA announced that a joint meeting of the Hematology and 
    Pathology Devices Panel and the Immunology Devices Panel of the Medical 
    Devices Advisory Committee would be held on September 4, 1998.
        On page 43401, in the second column, the ``Date and Time'' portion 
    is amended to read as follows:
        Date and Time: The meeting will be held on September 4, 1998, 8 
    a.m. to 3:30 p.m.
        On page 43401, in the third column, the ``Procedure'' portion is 
    amended to read as follows:
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by August 21, 
    1998. Oral presentations from the public will be scheduled between 
    approximately 8:15 a.m. and 8:45 a.m. * * *.
    
        Dated: August 24, 1998.
     Michael A. Friedman,
     Deputy Commissioner for Operations.
    [FR Doc. 98-23265 Filed 8-26-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
08/28/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-23265
Pages:
46054-46054 (1 pages)
PDF File:
98-23265.pdf